Daiichi Sankyo (China) Holdings to acquire Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales - MarketLine Financial Deals

Daiichi Sankyo (China) Holdings to acquire Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales

Daiichi Sankyo (China) Holdings to acquire Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales - MarketLine Financial Deals
Daiichi Sankyo (China) Holdings to acquire Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales
Published Apr 20, 2012
2 pages — Published Apr 20, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

...Daiichi Sankyo (China) Holdings, Co., Ltd., a wholly-owned subsidiary of Daiichi Sankyo Company, Limited (Daiichi Sankyo), has entered into an agreement to acquire the entire equity in Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales Co., Ltd. (Xinshengyuan) from Shanghai Xinshengyuan Pharmaceutical (Group) Co., Ltd. Daiichi Sankyo is a Japan-based pharmaceutical company engaged in the research, development, manufacture, and marketing of pharmaceutical products. Xinshengyuan is engaged in importing and sale of pharmaceuticals. Target Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales Co., Ltd. Acquirer Daiichi Sankyo (China) Holdings, Co., Ltd. Seller/Vendor Shanghai Xinshengyuan Pharmaceutical (Group) Co., Ltd. Deal status Announced Deal category Acquisition Deal sub-category 100% acquisition Date of announcement Apr 20, 2012...

  
Source:
Document ID
MA106817_120423
Country
Country
Ticker
4568=JP
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Daiichi Sankyo (China) Holdings to acquire Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales" Apr 20, 2012. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Daiichi-Sankyo-China-Holdings-to-acquire-Shanghai-Xinshengyuan-Pharmaceutical-Group-Medicine-Chemical-Reagents-Sales-2052-80518>
  
APA:
MarketLine Financial Deals. (2012). Daiichi Sankyo (China) Holdings to acquire Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales Apr 20, 2012. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Daiichi-Sankyo-China-Holdings-to-acquire-Shanghai-Xinshengyuan-Pharmaceutical-Group-Medicine-Chemical-Reagents-Sales-2052-80518>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.